Richard L Miller, Ph.D. - Publications

1971-1975 Northwestern University, Evanston, IL 
 1990-2014 University of Nebraska at Kearney, Kearney, NE, United States 
 2014- Texas A&M - Kingsville 
social influence, interpersonal attraction, social comparison processes, cross-cultural psychology, environmental psychology, organizational behavior, scholarship of teaching and learning

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Philbin VJ, Dowling DJ, Gallington LC, Cortés G, Tan Z, Suter EE, Chi KW, Shuckett A, Stoler-Barak L, Tomai M, Miller RL, Mansfield K, Levy O. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. The Journal of Allergy and Clinical Immunology. 130: 195-204.e9. PMID 22521247 DOI: 10.1016/J.Jaci.2012.02.042  0.01
2012 Miller RL, Buxton WA. The effects of managerial transition training on organizational performance Leadership and Organization Development Journal. 33: 464-476. DOI: 10.1108/01437731211241256  0.01
2011 Miller RL, Rycek RF, Fritson K. The effects of high impact learning experiences on student engagement Procedia - Social and Behavioral Sciences. 15: 53-59. DOI: 10.1016/J.Sbspro.2011.03.050  0.01
2008 Balcetis E, Dunning D, Miller RL. Do collectivists know themselves better than individualists? Cross-cultural studies of the holier than thou phenomenon. Journal of Personality and Social Psychology. 95: 1252-67. PMID 19025282 DOI: 10.1037/A0013195  0.4
2008 Miller RL, Meng TC, Tomai MA. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News & Perspectives. 21: 69-87. PMID 18389099  0.01
2007 Tomai MA, Miller RL, Lipson KE, Kieper WC, Zarraga IE, Vasilakos JP. Resiquimod and other immune response modifiers as vaccine adjuvants. Expert Review of Vaccines. 6: 835-47. PMID 17931162 DOI: 10.1586/14760584.6.5.835  0.01
2007 Shi Y, White D, He L, Miller RL, Spaner DE. Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents. Cancer Research. 67: 1823-31. PMID 17308125 DOI: 10.1158/0008-5472.CAN-06-2381  0.01
2007 Torres A, Storey L, Anders M, Miller RL, Bulbulian BJ, Jin J, Raghavan S, Lee J, Slade HB, Birmachu W. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream. Journal of Translational Medicine. 5: 7. PMID 17257431 DOI: 10.1186/1479-5876-5-7  0.01
2007 Hammerbeck DM, Burleson GR, Schuller CJ, Vasilakos JP, Tomai M, Egging E, Cochran FR, Woulfe S, Miller RL. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antiviral Research. 73: 1-11. PMID 16959331 DOI: 10.1016/j.antiviral.2006.07.011  0.01
2006 von Bernuth H, Ku CL, Rodriguez-Gallego C, Zhang S, Garty BZ, Maródi L, Chapel H, Chrabieh M, Miller RL, Picard C, Puel A, Casanova JL. A fast procedure for the detection of defects in Toll-like receptor signaling. Pediatrics. 118: 2498-503. PMID 17142536 DOI: 10.1542/peds.2006-1845  0.01
2006 D'Sa EJ, Miller RL, Del Castillo C. Bio-optical properties and ocean color algorithms for coastal waters influenced by the Mississippi River during a cold front. Applied Optics. 45: 7410-28. PMID 16983431  0.01
2006 Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, ... Miller RL, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (New York, N.Y.). 314: 308-12. PMID 16973841 DOI: 10.1126/Science.1128346  0.01
2006 Inglefield JR, Larson CJ, Gibson SJ, Lebrec H, Miller RL. Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry. Journal of Biomolecular Screening. 11: 575-85. PMID 16760371 DOI: 10.1177/1087057106288051  0.01
2006 Levy O, Suter EE, Miller RL, Wessels MR. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood. 108: 1284-90. PMID 16638933 DOI: 10.1182/blood-2005-12-4821  0.01
2006 Tomic J, White D, Shi Y, Mena J, Hammond C, He L, Miller RL, Spaner DE. Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 176: 3830-9. PMID 16517754 DOI: 10.4049/Jimmunol.176.6.3830  0.01
2006 Thatcher TH, Luzina I, Fishelevich R, Tomai MA, Miller RL, Gaspari AA. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance. The Journal of Investigative Dermatology. 126: 821-31. PMID 16439962 DOI: 10.1038/sj.jid.5700167  0.01
2005 Yang K, Puel A, Zhang S, Eidenschenk C, Ku CL, Casrouge A, Picard C, von Bernuth H, Senechal B, Plancoulaine S, Al-Hajjar S, Al-Ghonaium A, Maródi L, Davidson D, Speert D, ... Miller RL, et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity. 23: 465-78. PMID 16286015 DOI: 10.1016/J.Immuni.2005.09.016  0.01
2005 Spaner DE, Miller RL, Mena J, Grossman L, Sorrenti V, Shi Y. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Leukemia & Lymphoma. 46: 935-9. PMID 16019542 DOI: 10.1080/10428190500054426  0.01
2005 Gerster JF, Lindstrom KJ, Miller RL, Tomai MA, Birmachu W, Bomersine SN, Gibson SJ, Imbertson LM, Jacobson JR, Knafla RT, Maye PV, Nikolaides N, Oneyemi FY, Parkhurst GJ, Pecore SE, et al. Synthesis and structure-activity-relationships of 1H-imidazo[4,5-c]quinolines that induce interferon production. Journal of Medicinal Chemistry. 48: 3481-91. PMID 15887957 DOI: 10.1021/jm049211v  0.01
2004 Miller RL, Miller DC. Facility profile. Children's hospital supports the whole family. Health Facilities Management. 17: 12-3. PMID 15373271  0.01
2004 Vance GS, Greenwell H, Miller RL, Hill M, Johnston H, Scheetz JP. Comparison of an allograft in an experimental putty carrier and a bovine-derived xenograft used in ridge preservation: a clinical and histologic study in humans. The International Journal of Oral & Maxillofacial Implants. 19: 491-7. PMID 15346745  0.01
2003 Iasella JM, Greenwell H, Miller RL, Hill M, Drisko C, Bohra AA, Scheetz JP. Ridge preservation with freeze-dried bone allograft and a collagen membrane compared to extraction alone for implant site development: a clinical and histologic study in humans. Journal of Periodontology. 74: 990-9. PMID 12931761 DOI: 10.1902/jop.2003.74.7.990  0.01
2002 Gibson SJ, Lindh JM, Riter TR, Gleason RM, Rogers LM, Fuller AE, Oesterich JL, Gorden KB, Qiu X, McKane SW, Noelle RJ, Miller RL, Kedl RM, Fitzgerald-Bocarsly P, Tomai MA, et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cellular Immunology. 218: 74-86. PMID 12470615 DOI: 10.1016/S0008-8749(02)00517-8  0.01
2002 Rautenschlein S, Sheikh AM, Patnayak DP, Miller RL, Sharma JM, Goyal SM. Effect of an immunomodulator on the efficacy of an attenuated vaccine against avian pneumovirus in turkeys. Avian Diseases. 46: 555-61. PMID 12243518 DOI: 10.1637/0005-2086(2002)046[0555:Eoaiot]2.0.Co;2  0.01
2002 Liu CC, Carder KL, Miller RL, Ivey JE. Fast and accurate model of underwater scalar irradiance. Applied Optics. 41: 4962-74. PMID 12206203 DOI: 10.1364/Ao.41.004962  0.01
Show low-probability matches.